Author
Lisa M. Kopp
Also Known As
L Kopp, L.M. Kopp, Lisa Kopp, Lisa M Kopp, Lisa M. Kopp, P Tran, for the Children’s Oncology Group
55
Publications
1.4K
Citations
16
H-Index
36
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 7 | 7 | 851 |
2 | Immunology | 5 | 5 | 820 |
3 | Cell Biology | 2 | 2 | 715 |
4 | Cellular Therapies | 2 | 2 | 663 |
5 | Blood Transplantation | 1 | 1 | 16 |
Lisa M. Kopp
×
13
Publications
1.1K
Citations
12
H-Index
| Year | Citations | |
|---|---|---|
2012 | 647 | |
Phase II trial of the glycoprotein non-metastatic B-targeted antibody–drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Children's Oncology Group Lisa M. Kopp, Suman Malempati, Mark Krailo, Phase Ii TrialMedicineImmunologyPathologyRecurrent Osteosarcoma Aost1521 | 2019 | 76 |
2013 | 68 | |
2023 | 68 | |
2021 | 53 | |
2014 | 34 | |
2014 | 21 | |
2008 | 20 | |
2021 | 20 | |
2016 | 16 |
Page 1
Page 1